Artificial intelligence (AI) can enhance breast cancer screenings by prioritizing cases, allowing radiologists to focus on ...

A new report found that 9 of 10 small- to midsize businesses are not sure they will be able to provide health benefits to their employees in the near future.

A panel held during the Institute for Value-Based Medicine event in Chicago on August 14, 2025, included discussions of ...

Climate-related disasters threaten US drug production, highlighting vulnerabilities in the pharmaceutical supply chain and ...

AI enhances mammography by reducing radiologists' workload by 40% while maintaining accuracy in breast cancer detection, ...

A new TIAA Institute report says solving workforce shortages with smarter hiring, training, and artificial intelligence could ...

Employers explore glucagon-like peptide-1 (GLP-1) therapies' impact on health benefits, showcasing accountability and ...

An expert discusses the expanded treatment options for refractory ITP, emphasizing accurate diagnosis, combination therapies targeting platelet production and destruction, and the evolving role of ...

James D. Chalmers, MBChB, PhD, explains that the ASPEN trial findings show that brensocatib reduces exacerbations, slows lung function decline at higher doses, and offers clinicians a long-awaited ...

New research reveals how triple-negative breast tumors use fatty tissue to fuel growth, highlighting the role of gap junctions in tumorigenesis.

In vivo CAR T-cell therapies promise to revolutionize cancer treatment, enhancing access and reducing costs while addressing financial toxicity and logistical barriers.

Jonathan Thompson, MD, MS, highlighted that reducing delays in molecular testing and treatment initiation is critical for improving lung cancer outcomes, and that clinical trial data suggest ...